![Anand Parikh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anand Parikh
Algemeen Directeur bij
FAETH THERAPEUTICS, INC.
Vermogen: 20 M $ op 30-06-2026
Profiel
Anand Parikh is the founder of Faeth Therapeutics LLC, founded in 2019, holding the titles of President, Chief Executive Officer & Director since 2026.
Mr. Parikh currently holds the position of Chairman, President & Chief Executive Officer at Faeth Therapeutics, Inc. since 2026.
Mr. Parikh completed undergraduate education at the University of Michigan and graduate education at New York University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-06-2026 | 817.699 ( 3,17% ) | 20 M $ | 30-06-2026 |
Actieve functies van Anand Parikh
| Bedrijven | Functie | Begin |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Algemeen Directeur | 13-06-2026 |
Faeth Therapeutics, Inc.
 Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Oprichter | 01-04-2019 |
Opleiding van Anand Parikh
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
9
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
